LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis.
Liang Y, Song X, Li Y, Chen B, Zhao W, Wang L, Zhang H, Liu Y, Han D, Zhang N, Ma T, Wang Y, Ye F, Luo D, Li X, Yang Q.
Liang Y, et al. Among authors: zhang n, zhang h.
Mol Cancer. 2020 May 8;19(1):85. doi: 10.1186/s12943-020-01206-5.
Mol Cancer. 2020.
PMID: 32384893
Free PMC article.
Retracted.